Proteomics data in this study demonstrated systemic downregulation of pathways and processes associated with mitochondria, impaired fatty acid metabolism, and increased insulin signalling in hypertensives, often observed in obesity-driven cardiovascular damage (Table 3, Supplementary Figure S4) [66–69]. This evidence concerns the gene INS and obesity disorder.